Latest News & Features
Americas
Google’s new contact lens sensor is just one of the latest eye-based devices that has vast potential in the field of medicine. LSIPR reports. 27 November 2014
Big Pharma
There still are some cultural, legal and procedural barriers that must be overcome before the potential of Brazil’s life sciences sector can be realised, as Gabriel Di Blasi and Mellina Mamede of Di Blasi, Parente & Associados explain. 27 November 2014
Big Pharma
The current regulations in Mexico provide a legal framework for protecting genetic resources, but the framework for investing in new biotechnology is still not clear, as Karla Roxana Aispuro Castro and Mariana González Vargas of Becerril, Coca & Becerril report. 27 November 2014
Americas
The Supreme Court of Canada was expected to bring the Canadian law on utility more into line with other jurisdictions, but those hopes have now received a setback, as Gunars Gaikis of Smart & Biggar/Fetherstonhaugh reports. 27 November 2014
Asia
UK medical research charity MRC Technology has teamed up with Chinese pharmaceutical company Yabao as part of an effort to discover and develop treatments for Parkinson’s disease. 26 November 2014
Big Pharma
At first glance, it might seem odd for a company to both divide blood plasma and fight the side-effects of cancer treatment. But not for PlasmaTech Biopharmaceuticals, which tells LSIPR about how the company does it and also protects its IP. 26 November 2014
Americas
US pharmaceutical company Supernus Pharmaceuticals has sued Zydus Pharmaceuticals and Cadila Healthcare accusing them of infringing patents covering its antiepileptic drug, Trokendi XR (topiramate). 25 November 2014
Big Pharma
A new EU policy will require pharmaceutical companies to provide clinical trial data when seeking marketing approval for their drugs. But how will they ensure adequate IP protection while embracing the new culture of transparency? LSIPR reports. 25 November 2014
Americas
Steptoe & Johnson has added a partner to its New York IP team. 24 November 2014
Europe
A lawyer from GlaxoSmithKline has said the Unified Patent Court will take ten years to overcome teething problems. 20 November 2014